Investment Stage

Focus Areas

About Investor

Mark Angelino serves as a Venture Partner at Third Rock Ventures, focusing on investments in biotech, pharmaceuticals, and manufacturing sectors. He typically invests at the seed and Series A stages with an investment range of $100K - $5.0M. Angelino has a PhD from MIT and a Bachelor's degree from The Cooper Union for the Advancement of Science and Art, bringing strong technical expertise to his investment activities. He has been involved with various biotech companies including Arbor Biotechnologies and has served as chief strategy and operating officer at Soufflé, an RNA biotech company founded by Robert Langer.